Abstract
Objectives
To compare effects of intensity-modulated radiotherapy (IMRT) with those of conventional radiotherapy on quality of life (QoL) and severity of xerostomia in patients with head and neck cancer.
Material and methods
PubMed, Cochrane, and Embase databases were searched to July 1, 2019, to identify relevant studies, using the following terms: radiotherapy, head and neck cancer, quality of life, cognition, xerostomia, two-/three-dimensional conformal radiation therapy, IMRT, conformal proton beam radiation therapy, stereotactic radiosurgery, and volumetric modulated arc therapy. The outcomes of interest were QoL measured by global health status; emotional, social, and cognitive function; and severity of xerostomia.
Results
Seven studies with a total of 761 patients (n = 369 with IMRT; n = 392 with conventional RT) were included in this study. Median patient age was 18–65 years. IMRT group patients had better global health status (pooled standardized mean difference [SMD] = 0.80, 95% CI 0.26 to 1.35, P = 0.004) and cognitive function (pooled SMD = 0.30, 95% CI 0.06 to 0.54, P = 0.013) than the conventional RT group. Patients receiving IMRT also had significantly lower scores for xerostomia than those receiving conventional RT (pooled SMD = − 0.60, 95% CI − 0.97 to − 0.24, P = 0.001). No differences were found in emotional function (P = 0.531) and social function (P = 0.348) between the two groups.
Conclusion
IMRT significantly improves QoL and reduces the severity of xerostomia in patients with head and neck cancer. Results of this study provide clinicians with guidelines for decisions on the use of IMRT versus conventional RT.
Similar content being viewed by others
Abbreviations
- CCB:
-
Concomitant boost technique
- EORTC:
-
European Organization for Research and Treatment of Cancer
- EORTC H&H35:
-
European Organization for Research and Treatment of Cancer head and neck cancer questionnaire
- EORTC QLQ-C30:
-
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire
- EORTC QLQ H&N35:
-
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Module for Head and Neck Cancer
- FACT:
-
Functional Assessment of Cancer Treatment questionnaire
- FACT H&H:
-
Functional Assessment of Cancer Treatment head and neck questionnaire
- GTV:
-
Gross tumor volume
- HR:
-
Hazard ratio
- HNQOL:
-
Head and Neck Quality of Life instrument
- IMRT:
-
Intensity-modulated radiotherapy
- OARs:
-
Organs at risk
- OR:
-
Odds ratio
- PGTVnx:
-
Primary gross tumor volume of nasopharynx
- PGTVnd:
-
Primary gross tumor volume of neck dissection
- PCTV:
-
Primary control tumor volume
- PCTVnd:
-
Primary control tumor volume of neck dissection
- PTV:
-
Planning target volume
- QoL:
-
Quality of life
- RT:
-
Radiation therapy
- SF-36:
-
Medical Outcomes Study Short-Form (36-item) Health Survey
- UWQOL:
-
University of Washington Quality of Life Questionnaire
- VMAT:
-
Volumetric modulated arc therapy
- XQ:
-
Xerostomia questionnaire
- 2D-RT:
-
Two-dimensional radiation therapy
- 3D-CRT:
-
Three-dimensional conformal radiation therapy
References
Marta GN, Silva V, de Andrade Carvalho H, de Arruda FF, Hanna SA, Gadia R, da Silva JLF, Correa SFM, Vita Abreu CEC, Riera R (2014) Intensity-modulated radiation therapy for head and neck cancer: systematic review and meta-analysis. Radiother Oncol 110:9–15
Kodaira T, Nishimura Y, Kagami Y, Ito Y, Shikama N, Ishikura S, Hiraoka M (2015) Definitive radiotherapy for head and neck squamous cell carcinoma: update and perspectives on the basis of EBM. Jpn J Clin Oncol 45:235–243
Chen J, Liu P, Wang Q, Wu L, Zhang X (2015) Influence of intensity-modulated radiation therapy on the life quality of patients with nasopharyngeal carcinoma. Cell Biochem Biophys 73:731–736
Pignon JP, le Maitre A, Maillard E, Bourhis J, Group M-NC (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4–14
Jensen AB, Hansen O, Jorgensen K, Bastholt L (1994) Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer. Acta Oncol 33:487–491
Bjordal K, Kaasa S (1995) Psychological distress in head and neck cancer patients 7-11 years after curative treatment. Br J Cancer 71:592–597
Wijers OB, Levendag PC, Braaksma MM, Boonzaaijer M, Visch LL, Schmitz PI (2002) Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors. Head Neck 24:737–747
Tribius S, Bergelt C (2011) Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: is there a worthwhile quality of life gain? Cancer Treat Rev 37:511–519
Lee SH, Kim TH, Kim JY, Park SY, Pyo HR, Shin KH, Kim DY, Kim JY, Cho KH (2006) Evaluation of parotid gland function following intensity modulated radiation therapy for head and neck cancer. Cancer Res Treat 38:84–91
Hayden JA, van der Windt DA, Cartwright JL, Cote P, Bombardier C (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158:280–286
Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J et al (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 343:d4002
Chen AM, Farwell DG, Luu Q, Vazquez EG, Lau DH, Purdy JA (2012) Intensity-modulated radiotherapy is associated with improved global quality of life among long-term survivors of head-and-neck cancer. Int J Radiat Oncol Biol Phys 84:170–175
Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, Adab F, Jefferies SJ, Scrase C, Yap BK, A'Hern RP, Sydenham MA, Emson M, Hall E, PARSPORT trial management group (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12:127–136
Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA (2009) Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys 74:1–8
Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH et al (2006) Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66:981–991
Jabbari S, Kim HM, Feng M, Lin A, Tsien C, Elshaikh M, Terrel JE, Murdoch-Kinch C, Eisbruch A (2005) Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys 63:725–731
Kam MC, Leung SF, Zee B, Chou MRC, Suen JJS, Mo F et al (2007) Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasophayngeal carcinoma patients. J Clin Oncol 25:4873–4879
Welsh LC, Dunlop AW, McGovern T, McQuaid D, Dean JA, Gulliford SL, Bhide SA, Harrington KJ, Nutting CM, Newbold KL (2014) Neurocognitive function after (chemo)-radiotherapy for head and neck cancer. Clin Oncol (R Coll Radiol) 26:765–775
Zhang B, Mo Z, Du W, Wang Y, Liu L, Wei Y (2015) Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: a systematic review and meta-analysis. Oral Oncol 51:1041–1046
Gupta T, Kannan S, Ghosh-Laskar S, Agarwal JP (2018) Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma. PLoS One 13:e0200137
Chandu A, Smith ACH, Rogers SN (2006) Health-related quality of life in oral cancer: a review. J Oral Maxillofac Surg 64:495–502
Morton RP, Izzard ME (2003) Quality-of-life outcomes in head and neck cancer patients. World J Surg 27:884–889
Johnson JT, Ferretti GA, Nethery WJ, Valdez IH, Fox PC, Ng D, Muscoplat CC, Gallagher SC (1993) Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 329:390–395
Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA (2001) Xerostomia and its predictors following parotid-sparing irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 50:695–704
Funding
This research was supported by the National Natural Science Foundation of China (nos. 81771158, 81871337), Zhejiang Provincial Natural Science Foundation of China (nos. LY16H180007, LY13H180016),and the Science Foundation from Health Commission of Zhejiang Province (nos. 2013RCA001, 201522257, 2016KYA014).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 13 kb)
Rights and permissions
About this article
Cite this article
Ge, X., Liao, Z., Yuan, J. et al. Radiotherapy-related quality of life in patients with head and neck cancers: a meta-analysis. Support Care Cancer 28, 2701–2712 (2020). https://doi.org/10.1007/s00520-019-05077-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-019-05077-5